Anika Therapeutics Inc. announced that its HA-based bone void filler received 510(k) clearance from the U.S. FDA and is indicated for filling bone voids or defects of the skeletal system, which are not intrinsic to the stability of the bone, created during surgery or resulting from traumatic injury.
The Rule of Three: Mapping Physician Engagement
Cardiology, Dermatology, Endocrinology, Gastroenterology, Healthcare Communications Agencies, Healthcare Physicians, Hematology, Neurology, Obstetrics & Gynecology, Oncology, Ophthalmics, Orthopedics, Pain, Pediatrics, Physician Engagement, Primary Care, Psychiatry, Pulmonology, Rheumatology, Surveys, White PapersUnderstanding the nuances behind why a physician makes a decision regarding an information source when making a clinical decision is key to learning the best way to deliver content that will prompt an engagement.
